CompletedNot Applicable

Endoscopic Ultrasound vs Percutaneous Route for Liver Biopsy

United States40 participantsStarted 2019-07-25

Plain-language summary

This study is to evaluate and directly compare the technical success, tissue quality, diagnostic efficacy and safety profile of Percutaneous and Endoscopic Ultrasound-guided Liver Biopsy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All patients referred for liver biopsy for any reason
✓. Informed consent obtained from the patient
✓. ≥ 18 years old
✓. Able to undergo conscious sedation for EUS procedure

Exclusion criteria

✕. \<18 years old
✕. Unable to obtain informed consent from the patient
✕. Medically unfit for sedation
✕. Pregnant patients
✕. Presence of a mass lesion in the liver requiring biopsy visualized on cross-sectional imaging
✕. Irreversible coagulopathy as determined by platelet count \< 50,000 mm3 or International Normalized Ratio (INR) \> 1.5
✕. Unable to stop anticoagulation or anti-platelet therapy for 5 days prior to the procedure
✕. Hemophilia

What they're measuring

Diagnostic adequacy of the tissue sample

Timeframe: 24 hours

Trial details

NCT IDNCT04003766

SponsorAdventHealth

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-31

View on ClinicalTrials.gov More Liver Biopsy trials